SciELO - Scientific Electronic Library Online

 
vol.137 número4Sarcoma histiocítico cutáneo: Reporte de un casoComparación del tratamiento médico y quirúrgico en pacientes con obesidad grado III (obesidad mórbida) índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

CONTE L, Guillermo; BRAGGIO, Esteban; FIGUEROA, Gastón  y  FONSECA, Rafael. Genetic markers as prognostic factors in multiple myeloma. Rev. méd. Chile [online]. 2009, vol.137, n.4, pp.552-558. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872009000400015.

The search for prognostic factors in multiple myeloma has identified the genetic profile of the tumor as the main determinant of patient survival and response to treatment. There is an association between a dismal prognosis and the presence of t(4:14) translocations or 17p deletion, determined by fluorescent in situ hybridization (FISH) or the detection of chromosome 13 deletion using conventional cytogenetic techniques. These alterations define a subpopulation that comprises 25% of patients with a bad prognosis even if they are treated with high dose chemotherapy These patients should be early derived to more specific therapies. In the other hand, the other 75% of patients without a genetic risk factor, have a higher probability of success with conventional treatment.

Palabras clave : Citogenetics; Genetic markers; multiple myeloma.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons